Karis Bio

HealthcareSeries BSeoul, South Koreakarisbio.com

Latest round

Series B

Last raised

Mar 2025

Total raised

$17M

Investors

8

About Karis Bio

Based in Seoul, South Korea, and founded in 2020, Karis Bio Inc. is a company that develops technology to use cell-based therapy techniques for treatment of cardiovascular diseases. The company was established by Young-Seop Yoon, a professor specializing in the Department of Biomedical Sciences at Yonsei University, who has been focusing on human stem cell and tissue engineering research for the past 20 years. CEO Yoon came to Yonsei University as a special professor since 2015 while serving as a chair professor in the Department of Cardiology and Medical Engineering at Emory University and as the head of the Stem Cell Research Center. In 2020, Karis Bio Inc. has been awarded U-Tech Valley Business by Korea Technology Finance Corporation. The company develops a technology that differentiates human induced pluripotent stem cells (hiPSCs) into endothelial cells (EC).

Who invested in Karis Bio

8 investors across 2 rounds

See all investors in Karis Bio

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Mar 4, 2025

    Amount

    $7.9M

    Investors

    Locked

  2. Series A

    Aug 2, 2021

    Amount

    $8.9M

    Investors

    Locked

Questions about Karis Bio

Who invested in Karis Bio?

Karis Bio has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Karis Bio raised?

Karis Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Karis Bio last raise money?

Karis Bio's most recent round on record is a Series B, in Mar 2025.

What does Karis Bio do?

Based in Seoul, South Korea, and founded in 2020, Karis Bio Inc.

Where is Karis Bio headquartered?

Karis Bio is headquartered in Seoul, South Korea.

Which VCs invest in companies like Karis Bio?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Hengxu Capital and Riverhead Capital back healthcare companies at Karis Bio's stage. Their profiles are linked below.

Raising like Karis Bio? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.